Repository logo
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    Have you forgotten your password?
Repository logo
  • Communities & Collections
  • All of DSpace
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Pake, IAR"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • No Thumbnail Available
    Item
    Residual immune dysregulation in human immunodeficiency virus infection: implications for hypersensitivity
    (Medip Academy, 2025-06) Pake, IAR; Widiasa, AAM; Suryana, K
    Residual immune dysregulation persists in people living with human immunodeficiency virus (PLWHIV) despite antiretroviral therapy (ART), characterized by chronic immune activation and imbalances in immune responses that increase the risk of allergic conditions such as drug hypersensitivity, atopic dermatitis (AD), and asthma. This literature review explores the mechanisms underlying immune dysregulation in PLWHIV and its implications for hypersensitivity reactions. HIV infection shifts the immune response from Th1 to Th2, increasing cytokine production, particularly IL-4 and IL-13, and elevating IgE levels, contributing to allergic reactions. Drug hypersensitivity, especially to nevirapine and abacavir, occurs more frequently in PLWHIV, with a higher risk of severe conditions such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). The management of allergies in PLWHIV remains challenging due to persistent immune dysregulation, limited therapeutic options, and the lack of specific clinical guidelines. Understanding these immunological changes is crucial for developing better strategies for allergy prevention and management in this population

IMSEAR is the collaborative product of Health Literature, Library and Information Services (HELLIS) Network Member Libraries in the WHO South-East Asia Region.
HELLIS is coordinated by WHO Regional Office for South-East Asia.

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback